NCT03949257

Brief Summary

A prospective study to investigate the dynamic changes of gut microbiota through colonic transendoscopic enteral tubing in patients with ulcerative colitis after fecal microbiota transplantation.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 12, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 14, 2019

Completed
18 days until next milestone

Study Start

First participant enrolled

June 1, 2019

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2019

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2019

Completed
Last Updated

May 14, 2019

Status Verified

May 1, 2019

Enrollment Period

3 months

First QC Date

May 12, 2019

Last Update Submit

May 12, 2019

Conditions

Keywords

transendoscopic enteral tubinggut microbiotaulcerative colitis

Outcome Measures

Primary Outcomes (1)

  • changes of gut microbiota

    gut microbiota will be collected through the colonic TET

    7 days

Secondary Outcomes (1)

  • frequency of defecation

    7 days

Study Arms (1)

colonic TET and FMT

EXPERIMENTAL

gut microbiota will be collected through the colonic TET after FMT

Device: colonic transendoscopic enteral tubing

Interventions

Colonic transendoscopic enteral tubing (TET) is a novel, safe, convenient, and reliable way for fecal microbiota transplantation (FMT) and the whole-colon enema treatment.

Also known as: fecal microbiota transplantation
colonic TET and FMT

Eligibility Criteria

Age7 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients were diagnosed with mild or moderate ulcerative colitis.
  • Patients need colonic TET and FMT
  • Must be able to colonic TET and no contraindication by endoscopic examination, consent colon TET implantation and not associated with severe intestinal lesions such as fistula, stenosis, complex perianal lesions, severe ileocecal or ascending colon lesions resulting in no proper site for titanium clip fixation.
  • Age \> 7 years old and \< 65 years old

You may not qualify if:

  • gut microbiota was not collected successfully

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical Center for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University

Nanjing, Jiangsu, 210011, China

Location

Related Publications (2)

  • Peng Z, Xiang J, He Z, Zhang T, Xu L, Cui B, Li P, Huang G, Ji G, Nie Y, Wu K, Fan D, Zhang F. Colonic transendoscopic enteral tubing: A novel way of transplanting fecal microbiota. Endosc Int Open. 2016 Jun;4(6):E610-3. doi: 10.1055/s-0042-105205. Epub 2016 Apr 28.

    PMID: 27556065BACKGROUND
  • Westwood DA, Alexakis N, Connor SJ. Transparent cap-assisted colonoscopy versus standard adult colonoscopy: a systematic review and meta-analysis. Dis Colon Rectum. 2012 Feb;55(2):218-25. doi: 10.1097/DCR.0b013e31823461ef.

    PMID: 22228167BACKGROUND

MeSH Terms

Conditions

Colitis, Ulcerative

Interventions

Fecal Microbiota Transplantation

Condition Hierarchy (Ancestors)

ColitisGastroenteritisGastrointestinal DiseasesDigestive System DiseasesInflammatory Bowel DiseasesColonic DiseasesIntestinal Diseases

Intervention Hierarchy (Ancestors)

Biological TherapyTherapeutics

Study Officials

  • faming zhang, MD; PhD

    The Second Hospital of Nanjing Medical University

    STUDY CHAIR

Central Study Contacts

faming zhang, MD; PhD

CONTACT

min dai, MD; PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 12, 2019

First Posted

May 14, 2019

Study Start

June 1, 2019

Primary Completion

September 1, 2019

Study Completion

December 1, 2019

Last Updated

May 14, 2019

Record last verified: 2019-05

Locations